| Literature DB >> 32808367 |
Xiaowei Zhou1, Haiyang Liu2, Mingyu Zhang1, Chunyu Li1, Guohui Li1.
Abstract
OBJECTIVES: Lung cancer has the highest mortality rate among the various types of cancer. Panax ginseng (C. A. Mey). is a popular anti-cancer herbal supplement. The quality control of ginseng is crucial to ensure its clinical efficacy. This study aimed to establish new quality control methods for ginseng and to identify its main active components responsible for lung cancer treatment.Entities:
Keywords: Lewis lung cancer cells; Panax ginseng; ginsenoside Ro; spectrum-effect relationships; traditional Chinese medicine
Mesh:
Substances:
Year: 2020 PMID: 32808367 PMCID: PMC8048684 DOI: 10.1002/pca.2980
Source DB: PubMed Journal: Phytochem Anal ISSN: 0958-0344 Impact factor: 3.373
FIGURE 1UPLC fingerprints of reference standards (A), test samples (B) and all ginseng samples (C) six peaks were represented as follows: (a) ginsenoside Rg1; (b) ginsenoside Re; (c) ginsenoside Rb1; (d) ginsenoside Rc; (e) ginsenoside Ro; (f) ginsenoside Rd
Peak area of six common peaks identified by ultra‐high‐performance liquid chromatography (UPLC)
| Sample | Peak area of each compound | |||||
|---|---|---|---|---|---|---|
| a | b | c | d | e | f | |
|
| 18.39 | 18.63 | 23.48 | 24.07 | 24.41 | 25.42 |
| S1 | 1563 | 980 | 1112 | 605 | 328 | 464 |
| S2 | 1667 | 1302 | 2053 | 595 | 331 | 587 |
| S3 | 1362 | 985 | 972 | 377 | 265 | 325 |
| S4 | 1497 | 1116 | 1093 | 505 | 293 | 339 |
| S5 | 2644 | 2228 | 1850 | 2023 | 893 | 445 |
| S6 | 3553 | 2351 | 2366 | 1620 | 1311 | 248 |
| S7 | 951 | 660 | 887 | 745 | 263 | 468 |
| S8 | 2487 | 2395 | 2003 | 1381 | 818 | 326 |
| S9 | 3208 | 2890 | 2059 | 1263 | 663 | 298 |
| S10 | 2819 | 2497 | 2165 | 1598 | 709 | 303 |
| S11 | 3758 | 1941 | 2231 | 1302 | 688 | 220 |
| S12 | 1895 | 1323 | 1192 | 911 | 557 | 421 |
| S13 | 2243 | 1706 | 1518 | 1039 | 701 | 357 |
| S14 | 2106 | 1979 | 1445 | 1066 | 669 | 327 |
| S15 | 2928 | 1431 | 1567 | 1116 | 843 | 283 |
| S16 | 2796 | 1367 | 1791 | 1078 | 1137 | 434 |
| S17 | 1891 | 1483 | 1095 | 890 | 598 | 498 |
| S18 | 2531 | 2193 | 1955 | 1128 | 938 | 470 |
| RSD% | 33.41 | 36.37 | 30.53 | 41.87 | 45.93 | 66.17 |
RSD = σ/μ × 100; RSD, relative standard deviation; σ, standard deviation; μ, average value of peak area. (a) Ginsenoside Rg1, (b) ginsenoside Re, (c) ginsenoside Rb1, (d) ginsenoside Rc, (e) ginsenoside Ro, (f) ginsenoside Rd.
FIGURE 2Inhibitory effect of ginseng on LLC cells. (A) Effects of 18 batches of ginseng samples on the viability of LLC cells. (B) IC50 values of ginseng samples on LLC cells
FIGURE 3Heat map of 18 batches of ginseng and six chemical compounds (right of the map) [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 4Correlation analysis. (A) Pearson correlation coefficient between the IC50 value and peak area of six common peaks. (B) Thermograph of the correlation analysis of all factors [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 5Validation of inhibitory effect of ginsenosides Rg1, Rb1, and Ro on LLC cells